Chengdu Shengnuo Biopharmaceutical Co., Ltd. to Participate in PHARMEDI VIETNAM 2025

chengdu Shengnuo Biopharmaceutical Co., Ltd., a leader in the domestic peptide raw material production sector, officially announced its participation in PHARMEDI VIETNAM 2025, which will be held in Ho Chi Minh City, Vietnam from September 24 to 27, 2025. This participation marks a key initiative for Shengnuo Biopharma to expand its international market presence and enhance international exchange and cooperation.​

Shengnuo Biopharma has long focused on the R&D and production of peptide raw materials. After years of development, it has established a world-class R&D and production platform for pharmaceutical peptides, boasting a number of core patented technologies that cover key links such as high-difficulty peptide synthesis, complex peptide modification, and large-scale peptide production. With advanced technology and strict quality control, the company's products have not only gained wide recognition in the domestic market but also been exported to many countries and regions overseas.​

PHARMEDI VIETNAM is a highly influential international event in the healthcare industry of Southeast Asia, having been successfully held for multiple sessions. The exhibition brings together elites from the global medical industry, covering the entire industrial chain including medical products, equipment, pharmaceuticals, hospital construction, and rehabilitation services. It provides an excellent platform for participating enterprises to showcase their offerings and explore cooperation opportunities. This time, Shengnuo Biopharma will showcase its core peptide raw material products at Booth No. B-6, aiming to present its outstanding peptide-related technologies and high-quality products to global customers, seek more international cooperation opportunities, and further expand its presence in the Southeast Asian market.​

In recent years, driven by Vietnam's national strategy "Healthy Vietnam 2030", the country's medical market has witnessed explosive growth, with a steady surge in demand for high-quality pharmaceutical products. A relevant person in charge of Shengnuo Biopharma stated, "The Vietnamese market holds great potential, and we attach great importance to this exhibition opportunity. We hope to gain a better understanding of the needs of the Vietnamese market through in-depth exchanges with local and international industry partners, provide higher-quality peptide raw material products and solutions to local customers, and jointly promote the development of the regional medical and health industry."​

During the exhibition, the Shengnuo Biopharma team will provide visitors with detailed introductions to the characteristics, advantages, and application fields of the company's products at the booth, and conduct in-depth discussions with potential customers on cooperation matters. Meanwhile, the company also looks forward to learning about cutting-edge international technologies and industry experience through this exhibition, injecting new impetus into its continuous innovation and development.​

If you are interested in Shengnuo Biopharma's products or wish to communicate and cooperate with us during the exhibition, please feel free to visit Booth No. B-6 at the Saigon Exhibition & Convention Center (SECC) in Ho Chi Minh City. We look forward to your arrival!